Immunotherapy & Immuno-Oncology
Part of Healthcare - Oncology
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 JNJ | Johnson & Johnson | $0.5t | $232.35 | +1.8% | 8.0M |
 ABBV | ABBVIE INC. | $384.7b | $226.50 | +0.7% | 6.2M |
 MRK | Merck & Co., Inc. | $293.2b | $120.66 | +0.3% | 16.0M |
 AZN | AstraZeneca PLC | $287.9b | $185.08 | +1.8% | 2.3M |
 AMGN | Amgen Inc | $181.8b | $349.61 | +1.2% | 3.5M |
 BMY | Bristol-Myers Squibb Co. | $116.8b | $57.00 | +0.7% | 9.6M |
 REGN | Regeneron Pharmaceuticals Inc | $64.5b | $635.40 | +1.1% | 975.8K |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $24.7b | $55.88 | +1.6% | 6.0M |
 MRNA | Moderna, Inc. Common Stock | $18.7b | $47.41 | -8.1% | 6.1M |
 IBRX | ImmunityBio, Inc. Common Stock | $7.9b | $6.92 | -5.1% | 13.8M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
 CGON | CG Oncology, Inc. Common stock | $5.5b | $53.72 | -4.2% | 967.3K |
 RCUS | Arcus Biosciences, Inc. | $3.2b | $22.54 | -8.7% | 1.0M |
 NKTR | Nektar Therapeutics | $2.2b | $57.39 | -3.2% | 1.0M |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.8b | $4.22 | -3.6% | 19.7M |
 SNDX | Syndax Pharmaceuticals, Inc. | $1.7b | $17.31 | -3.9% | 2.7M |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $1.7b | $8.22 | -9.1% | 6.7M |
 IMTX | Immatics N.V. Ordinary Shares | $1.6b | $9.80 | -3.7% | 1.1M |
 PGEN | Precigen, Inc. Common Stock | $1.5b | $3.56 | -7.8% | 5.3M |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $1.5b | $87.08 | -4.6% | 417.4K |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.4b | $20.00 | -2.0% | 356.2K |
 CRVS | Corvus Pharmaceuticals, Inc. | $1.0b | $11.10 | -5.3% | 1.2M |
 CGEM | Cullinan Therapeutics, Inc. Common Stock | $1.0b | $13.51 | -6.4% | 753.8K |
 JANX | Janux Therapeutics, Inc. Common Stock | $0.9b | $13.34 | -3.0% | 490.6K |
 XNCR | Xencor, Inc. | $0.9b | $11.78 | -2.0% | 862.6K |
 OMER | Omeros Corporation | $0.8b | $9.79 | -4.5% | 1.7M |
 CTMX | CytomX Therapeutics, Inc. | $0.8b | $2.98 | -6.1% | 3.4M |
 AURA | Aura Biosciences, Inc. Common Stock | $0.8b | $6.63 | -2.5% | 347.1K |
 REPL | Replimune Group, Inc. | $0.7b | $9.47 | -4.0% | 4.6M |
 CADL | Candel Therapeutics, Inc. Common Stock | $0.6b | $8.51 | -8.3% | 2.0M |
 CBIO | Crescent Biopharma, Inc. Common Stock | $0.6b | $18.11 | -1.8% | 192.6K |
 CMPX | Compass Therapeutics, Inc. Common Stock | $428.6m | $2.03 | -4.7% | 3.1M |
 GLSI | Greenwich LifeSciences, Inc. | $362.6m | $22.34 | -5.6% | 179.9K |
 MGNX | MacroGenics, Inc. | $264.4m | $3.91 | -8.0% | 560.1K |
 CNTX | Context Therapeutics Inc. Common Stock | $261.9m | $1.73 | -14.8% | 821.7K |
 ALXO | ALX Oncology Holdings Inc. Common Stock | $255.7m | $1.53 | -1.9% | 858.5K |
 CGEN | Compugen Ltd | $248.8m | $2.10 | -5.4% | 242.6K |
 CHRS | Coherus Oncology, Inc. Common Stock | $245.3m | $1.45 | -8.3% | 908.7K |
 ELTX | Elicio Therapeutics, Inc. Common Stock | $218.3m | $13.21 | -5.2% | 114.9K |
 INDP | Indaptus Therapeutics, Inc. Common Stock | $199.3m | $3.62 | -23.8% | 2.8M |
 AGEN | Agenus Inc. | $145.7m | $3.23 | -4.9% | 434.6K |
 HURA | TuHURA Biosciences, Inc. Common Stock | $143.9m | $1.96 | -10.5% | 1.1M |
 GNLX | Genelux Corporation Common Stock | $136.8m | $2.92 | -5.2% | 166.2K |
 ONCY | Oncolytics Biotech, Inc. Common Shares | $124.1m | $0.85 | -1.6% | 1.1M |
 ANIX | Anixa Biosciences, Inc. | $90.5m | $2.45 | -6.5% | 110.2K |
 CUE | Cue Biopharma, Inc. | $88.6m | $29.71 | +0.2% | 92.2K |
 MAIA | MAIA Biotechnology, Inc. | $84.5m | $1.37 | -8.7% | 1.4M |
 XBIT | XBiotech Inc | $73.8m | $2.37 | -0.2% | 33.2K |
 BYSI | BeyondSpring Inc. Ordinary Shares | $69.1m | $1.64 | -4.1% | 24.0K |
 PDSB | PDS Biotechnology Corporation Common Stock | $62.0m | $1.02 | -16.0% | 1.6M |